Girardini JE, Napoli M, Piazza S, Rustighi A, Marotta C, Radaelli E, Capaci V, Jordan L, Quinlan P, Thompson A, Mano M, Rosato A, Crook T, Scanziani E, Means AR, Lozano G, Schneider C, Del Sal G

A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.

Cancer Cell 2011; 79-91. doi: 10.1016/j.ccr.2011.06.004

Leggi ora

Marcucci R, Brindle J, Paro S, Casadio A, Hempel S, Morrice N, Bisso A, Keegan LP, Del Sal G, O'Connell MA

Pin1 and WWP2 regulate GluR2 Q/R site RNA editing by ADAR2 with opposing effects.

EMBO J 2011; 4211-22. doi: 10.1038/emboj.2011.303

Leggi ora

Vilotti S, Biagioli M, Foti R, Dal Ferro M, Lavina ZS, Collavin L, Del Sal G, Zucchelli S, Gustincich S

The PML nuclear bodies-associated protein TTRAP regulates ribosome biogenesis in nucleolar cavities upon proteasome inhibition.

Cell Death Differ 2012; 488-500. doi: 10.1038/cdd.2011.118

Leggi ora

Napoli M, Girardini JE, Piazza S, Del Sal G

Wiring the oncogenic circuitry: Pin1 unleashes mutant p53.

Oncotarget 2011; 654-6. doi: 10.18632/oncotarget.329

Leggi ora

Grison A, Mantovani F, Comel A, Agostoni E, Gustincich S, Persichetti F, Del Sal G

Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin.

Proc Natl Acad Sci U S A 2011; 17979-84. doi: 10.1073/pnas.1106198108

Leggi ora

Napoli M, Girardini JE, Del Sal G

Polo-like kinase 2: a new exploitable target to undermine mutant p53-dependent chemoresistance.

Cell Cycle 2012; 438. doi: 10.4161/cc.11.3.19225

Leggi ora

Walerych D, Napoli M, Collavin L, Del Sal G

The rebel angel: mutant p53 as the driving oncogene in breast cancer.

Carcinogenesis 2012; 2007-17. doi: 10.1093/carcin/bgs232

Leggi ora

Sorrentino G, Mioni M, Giorgi C, Ruggeri N, Pinton P, Moll U, Mantovani F, Del Sal G

The prolyl-isomerase Pin1 activates the mitochondrial death program of p53.

Cell Death Differ 2013; 198-208. doi: 10.1038/cdd.2012.112

Leggi ora

Sonego M, Schiappacassi M, Lovisa S, Dall'Acqua A, Bagnoli M, Lovat F, Libra M, D'Andrea S, Canzonieri V, Militello L, Napoli M, Giorda G, Pivetta B, Mezzanzanica D, Barbareschi M, Valeri B, Canevari S, Colombatti A, Belletti B, Del Sal G, Baldassarre G

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.

EMBO Mol Med 2013; 707-22. doi: 10.1002/emmm.201201504

Leggi ora

Steger M, Murina O, Hühn D, Ferretti LP, Walser R, Hänggi K, Lafranchi L, Neugebauer C, Paliwal S, Janscak P, Gerrits B, Del Sal G, Zerbe O, Sartori AA

Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection.

Mol Cell 2013; 333-43. doi: 10.1016/j.molcel.2013.03.023

Leggi ora

Bisso A, Faleschini M, Zampa F, Capaci V, De Santa J, Santarpia L, Piazza S, Cappelletti V, Daidone M, Agami R, Del Sal G

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.

Cell Cycle 2013; 1679-87. doi: 10.4161/cc.24757

Leggi ora

Pegoraro S, Ros G, Piazza S, Sommaggio R, Ciani Y, Rosato A, Sgarra R, Del Sal G, Manfioletti G

HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness.

Oncotarget 2013; 1293-308. doi: 10.18632/oncotarget.1136

Leggi ora

Quy VC, Carnevale V, Manganaro L, Lusic M, Rossetti G, Leone V, Fenollar-Ferrer C, Raugei S, Del Sal G, Giacca M, Carloni P

HIV-1 integrase binding to its cellular partners: a perspective from computational biology.

Curr Pharm Des 2014; 3412-21. doi: 10.2174/13816128113199990631

Leggi ora

Bitomsky N, Conrad E, Moritz C, Polonio-Vallon T, Sombroek D, Schultheiss K, Glas C, Greiner V, Herbel C, Mantovani F, del Sal G, Peri F, Hofmann TG

Autophosphorylation and Pin1 binding coordinate DNA damage-induced HIPK2 activation and cell death.

Proc Natl Acad Sci U S A 2013; E4203-12. doi: 10.1073/pnas.1310001110

Leggi ora

Girardini JE, Marotta C, Del Sal G

Disarming mutant p53 oncogenic function.

Pharmacol Res 2014; 75-87. doi: 10.1016/j.phrs.2013.11.003

Leggi ora

Ciarapica R, Methot L, Tang Y, Lo R, Dali R, Buscarlet M, Locatelli F, del Sal G, Rota R, Stifani S

Prolyl isomerase Pin1 and protein kinase HIPK2 cooperate to promote cortical neurogenesis by suppressing Groucho/TLE:Hes1-mediated inhibition of neuronal differentiation.

Cell Death Differ 2014; 321-32. doi: 10.1038/cdd.2013.160

Leggi ora

Rustighi A, Zannini A, Tiberi L, Sommaggio R, Piazza S, Sorrentino G, Nuzzo S, Tuscano A, Eterno V, Benvenuti F, Santarpia L, Aifantis I, Rosato A, Bicciato S, Zambelli A, Del Sal G

Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast.

EMBO Mol Med 2014; 99-119. doi: 10.1002/emmm.201302909

Leggi ora

Castiglioni V, De Maglie M, Queliti R, Rustighi A, Del Sal G, Radaelli E

Immunohistochemical Characterization of a Renal Nephroblastoma in a Trp53-mutant and Prolyl Isomerase 1-deficient Mouse.

J Toxicol Pathol 2013; 423-7. doi: 10.1293/tox.2013-0021

Leggi ora

Restelli M, Lopardo T, Lo Iacono N, Garaffo G, Conte D, Rustighi A, Napoli M, Del Sal G, Perez-Morga D, Costanzo A, Merlo GR, Guerrini L

DLX5, FGF8 and the Pin1 isomerase control ΔNp63α protein stability during limb development: a regulatory loop at the basis of the SHFM and EEC congenital malformations.

Hum Mol Genet 2014; 3830-42. doi: 10.1093/hmg/ddu096

Leggi ora

Comel A, Sorrentino G, Capaci V, Del Sal G

The cytoplasmic side of p53's oncosuppressive activities.

FEBS Lett 2014; 2600-9. doi: 10.1016/j.febslet.2014.04.015

Leggi ora

Paneni F, Costantino S, Castello L, Battista R, Capretti G, Chiandotto S, D'Amario D, Scavone G, Villano A, Rustighi A, Crea F, Pitocco D, Lanza G, Volpe M, Del Sal G, Lüscher TF, Cosentino F

Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes.

Eur Heart J 2015; 817-28. doi: 10.1093/eurheartj/ehu179

Leggi ora

Sorrentino G, Comel A, Mantovani F, Del Sal G

Regulation of mitochondrial apoptosis by Pin1 in cancer and neurodegeneration.

Mitochondrion 2014; 88-96. doi: 10.1016/j.mito.2014.08.003

Leggi ora

Girardini JE, Walerych D, Del Sal G

Cooperation of p53 mutations with other oncogenic alterations in cancer.

Subcell Biochem 2014; 41-70. doi: 10.1007/978-94-017-9211-0_3

Leggi ora

Antonelli R, Pizzarelli R, Pedroni A, Fritschy JM, Del Sal G, Cherubini E, Zacchi P

Pin1-dependent signalling negatively affects GABAergic transmission by modulating neuroligin2/gephyrin interaction.

Nat Commun 2014; 5066. doi: 10.1038/ncomms6066

Leggi ora

Di Minin G, Bellazzo A, Dal Ferro M, Chiaruttini G, Nuzzo S, Bicciato S, Piazza S, Rami D, Bulla R, Sommaggio R, Rosato A, Del Sal G, Collavin L

Mutant p53 reprograms TNF signaling in cancer cells through interaction with the tumor suppressor DAB2IP.

Mol Cell 2014; 617-29. doi: 10.1016/j.molcel.2014.10.013

Leggi ora

Giorgi C, Bonora M, Sorrentino G, Missiroli S, Poletti F, Suski JM, Galindo Ramirez F, Rizzuto R, Di Virgilio F, Zito E, Pandolfi PP, Wieckowski MR, Mammano F, Del Sal G, Pinton P

p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner.

Proc Natl Acad Sci U S A 2015; 1779-84. doi: 10.1073/pnas.1410723112

Leggi ora

Mantovani F, Zannini A, Rustighi A, Del Sal G

Interaction of p53 with prolyl isomerases: Healthy and unhealthy relationships.

Biochim Biophys Acta 2015; 2048-60. doi: 10.1016/j.bbagen.2015.01.013

Leggi ora

Farra R, Dapas B, Baiz D, Tonon F, Chiaretti S, Del Sal G, Rustighi A, Elvassore N, Pozzato G, Grassi M, Grassi G

Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells.

Biochimie 2015; 85-95. doi: 10.1016/j.biochi.2015.02.015

Leggi ora

Sorrentino G, Comel A, Del Sal G

p53 orchestrates calcium signaling in vivo.

Cell Cycle 2015; 1343-4. doi: 10.1080/15384101.2015.1024583

Leggi ora

Taccioli C, Sorrentino G, Zannini A, Caroli J, Beneventano D, Anderlucci L, Lolli M, Bicciato S, Del Sal G

MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells.

Oncotarget 2015; 38854-65. doi: 10.18632/oncotarget.5749

Leggi ora

Di Agostino S, Sorrentino G, Ingallina E, Valenti F, Ferraiuolo M, Bicciato S, Piazza S, Strano S, Del Sal G, Blandino G

YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins.

EMBO Rep 2016; 188-201. doi: 10.15252/embr.201540488

Leggi ora

Walerych D, Lisek K, Del Sal G

Mutant p53: One, No One, and One Hundred Thousand.

Front Oncol 2015; 289. doi: 10.3389/fonc.2015.00289

Leggi ora

D'Artista L, Bisso A, Piontini A, Doni M, Verrecchia A, Kress TR, Morelli MJ, Del Sal G, Amati B, Campaner S

Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc.

Oncotarget 2016; 21786-98. doi: 10.18632/oncotarget.7846

Leggi ora

Garibaldi F, Falcone E, Trisciuoglio D, Colombo T, Lisek K, Walerych D, Del Sal G, Paci P, Bossi G, Piaggio G, Gurtner A

Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex.

Oncogene 2016; 3760-70. doi: 10.1038/onc.2016.51

Leggi ora

Agostoni E, Michelazzi S, Maurutto M, Carnemolla A, Ciani Y, Vatta P, Roncaglia P, Zucchelli S, Leanza G, Mantovani F, Gustincich S, Santoro C, Piazza S, Del Sal G, Persichetti F

Effects of Pin1 Loss in Hdh(Q111) Knock-in Mice.

Front Cell Neurosci 2016; 110. doi: 10.3389/fncel.2016.00110

Leggi ora

Walerych D, Lisek K, Sommaggio R, Piazza S, Ciani Y, Dalla E, Rajkowska K, Gaweda-Walerych K, Ingallina E, Tonelli C, Morelli MJ, Amato A, Eterno V, Zambelli A, Rosato A, Amati B, Wiśniewski JR, Del Sal G

Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer.

Nat Cell Biol 2016; 897-909. doi: 10.1038/ncb3380

Leggi ora

Walerych D, Lisek K, Del Sal G

Multi-omics reveals global effects of mutant p53 gain-of-function.

Cell Cycle 2016; 3009-3010. doi: 10.1080/15384101.2016.1215703

Leggi ora

Lo Sardo F, Forcato M, Sacconi A, Capaci V, Zanconato F, Di Agostino S, Del Sal G, Pandolfi PP, Strano S, Bicciato S, Blandino G

MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer.

Carcinogenesis 2017; 64-75. doi: 10.1093/carcin/bgw110

Leggi ora

Rustighi A, Zannini A, Campaner E, Ciani Y, Piazza S, Del Sal G

PIN1 in breast development and cancer: a clinical perspective.

Cell Death Differ 2017; 200-211. doi: 10.1038/cdd.2016.122

Leggi ora

Sorrentino G, Ruggeri N, Zannini A, Ingallina E, Bertolio R, Marotta C, Neri C, Cappuzzello E, Forcato M, Rosato A, Mano M, Bicciato S, Del Sal G

Glucocorticoid receptor signalling activates YAP in breast cancer.

Nat Commun 2017; 14073. doi: 10.1038/ncomms14073

Leggi ora

Lisek K, Walerych D, Del Sal G

Mutant p53-Nrf2 axis regulates the proteasome machinery in cancer.

Mol Cell Oncol 2017; e1217967. doi: 10.1080/23723556.2016.1217967

Leggi ora

Noto A, De Vitis C, Pisanu ME, Roscilli G, Ricci G, Catizone A, Sorrentino G, Chianese G, Taglialatela-Scafati O, Trisciuoglio D, Del Bufalo D, Di Martile M, Di Napoli A, Ruco L, Costantini S, Jakopin Z, Budillon A, Melino G, Del Sal G, Ciliberto G, Mancini R

Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.

Oncogene 2017; 4573-4584. doi: 10.1038/onc.2017.75

Leggi ora

Ibarra MS, Borini Etichetti C, Di Benedetto C, Rosano GL, Margarit E, Del Sal G, Mione M, Girardini J

Dynamic regulation of Pin1 expression and function during zebrafish development.

PLoS One 2017; e0175939. doi: 10.1371/journal.pone.0175939

Leggi ora

Campaner E, Rustighi A, Zannini A, Cristiani A, Piazza S, Ciani Y, Kalid O, Golan G, Baloglu E, Shacham S, Valsasina B, Cucchi U, Pippione AC, Lolli ML, Giabbai B, Storici P, Carloni P, Rossetti G, Benvenuti F, Bello E, D'Incalci M, Cappuzzello E, Rosato A, Del Sal G

A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action.

Nat Commun 2017; 15772. doi: 10.1038/ncomms15772

Leggi ora

Inviaci un messaggio